Expect Integrase Inhibitors to Gain an Edge in Treating HIV
October 2018
Updated guidelines will lead to a shift in preferred antiretroviral meds for treating HIV in adults.
Expect more patients to start regimens with integrase inhibitors...especially bictegravir (Biktarvy) or dolutegravir (Tivicay, etc).
That's because integrase inhibitors are often better tolerated than protease inhibitors, such as Prezista...or NON-nucleoside reverse transcriptase inhibitors (NNRTIs), such as Sustiva.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive